Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2010, Article ID 865031, 7 pages
http://dx.doi.org/10.4061/2010/865031
Research Article

An NOS3 Haplotype Is Protective against Hypertension in a Caucasian Population

1Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Tufts University School of Medicine, 800 Washington Street, Tufts MC no. 63, Boston, MA 02111, USA
2Department of Biomathematics, University of Thessaly School of Medicine, 2 Panepistimiou, Biopolis, Larissa 41100, Greece

Received 4 December 2009; Accepted 13 February 2010

Academic Editor: Tomohiro Katsuya

Copyright © 2010 Georgios D. Kitsios and Elias Zintzaras. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Vallance, J. Collier, and S. Moncada, “Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man,” The Lancet, vol. 2, no. 8670, pp. 997–1000, 1989. View at Google Scholar · View at Scopus
  2. J. P. Cooke and V. J. Dzau, “Nitric oxide synthase: role in the genesis of vascular disease,” Annual Review of Medicine, vol. 48, pp. 489–509, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. J. P. Casas, G. L. Cavalleri, L. E. Bautista, L. Smeeth, S. E. Humphries, and A. D. Hingorani, “Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review,” American Journal of Epidemiology, vol. 164, no. 10, pp. 921–935, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. G. E. Cooke, A. Doshi, and P. F. Binkley, “Endothelial nitric oxide synthase gene: prospects for treatment of heart disease,” Pharmacogenomics, vol. 8, no. 12, pp. 1723–1734, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. E. Zintzaras, G. Kitsios, and I. Stefanidis, “Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis,” Hypertension, vol. 48, no. 4, pp. 700–710, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Nejatizadeh, R. Kumar, T. Stobdan et al., “Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension,” Free Radical Biology and Medicine, vol. 44, no. 11, pp. 1912–1918, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. V. C. Sandrim, R. W. C. de Syllos, H. R. K. Lisboa, G. S. Tres, and J. E. Tanus-Santos, “Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients,” Nitric Oxide: Biology and Chemistry, vol. 16, no. 3, pp. 348–355, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. J. E. Tanus-Santos and A. Casella-Filho, “Endothelial nitric oxide synthase polymorphisms and susceptibility to hypertension: genotype versus haplotype analysis,” Hypertension, vol. 49, no. 1, article e1, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. E. Zintzaras, G. Kitsios, and I. Stefanidis, “Response to endothelial nitric oxide synthase polymorphisms and susceptibility to hypertension: genotype versus haplotype analysis,” Hypertension, vol. 49, no. 1, article e2, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. E. Zintzaras and J. Lau, “Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches,” Journal of Clinical Epidemiology, vol. 61, no. 7, pp. 634–645, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. H.-C. Yang, Y.-J. Liang, Y.-L. Wu et al., “Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan,” PLoS ONE, vol. 4, no. 5, article e5459, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. J. U. Kim, H. K. Chang, S. S. Lee et al., “Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease and rheumatic diseases with vasculitis,” Annals of the Rheumatic Diseases, vol. 62, no. 11, pp. 1083–1087, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Awata, T. Neda, H. Iizuka et al., “Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes,” Diabetes Care, vol. 27, no. 9, pp. 2184–2190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Y. Shi and L. He, “SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci,” Cell Research, vol. 15, no. 2, pp. 97–98, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. D. Y. Lin, Y. Hu, and B. E. Huang, “Simple and efficient analysis of disease association with missing genotype data,” American Journal of Human Genetics, vol. 82, no. 2, pp. 444–452, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. A. D. Skol, L. J. Scott, G. R. Abecasis, and M. Boehnke, “Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies,” Nature Genetics, vol. 38, no. 2, pp. 209–213, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. Vasilakou, V. Votteas, C. Kasparian et al., “Lack of association between endothelial nitric oxide synthase gene polymorphisms and risk of premature coronary artery disease in the Greek population,” Acta Cardiologica, vol. 63, no. 5, pp. 609–614, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Slatkin, “Linkage disequilibrium—understanding the evolutionary past and mapping the medical future,” Nature Reviews Genetics, vol. 9, no. 6, pp. 477–485, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. R. Kumar, A. Nejatizadeh, E. Arif et al., “Multi-locus interactions of vascular homeostasis genes in essential hypertension: a gender-based study,” Clinica Chimica Acta, vol. 405, no. 1-2, pp. 87–93, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. V. Vasconcellos, R. Lacchini, A. L. Jacob-Ferreira et al., “Endothelial nitric oxide synthase haplotypes associated with hypertension do not predispose to cardiac hypertrophy,” DNA and Cell Biology. In press.
  21. V. C. Sandrim, E. B. Coelho, F. Nobre, G. M. Arado, V. L. Lanchote, and J. E. Tanus-Santos, “Susceptible and protective eNOS haplotypes in hypertensive black and white subjects,” Atherosclerosis, vol. 186, no. 2, pp. 428–432, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. V. C. Sandrim, R. W. C. de Syllos, H. R. K. Lisboa, G. S. Tres, and J. E. Tanus-Santos, “Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus,” Atherosclerosis, vol. 189, no. 1, pp. 241–246, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. Q. Zhao, S.-Y. Su, S.-F. Chen, B. Li, and D.-F. Gu, “Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese,” Chinese Medical Journal, vol. 119, no. 13, pp. 1065–1071, 2006. View at Google Scholar · View at Scopus
  24. V. C. Sandrim, J. C. Yugar-Toledo, Z. Desta, D. A. Flockhart, H. Moreno Jr., and J. E. Tanus-Santos, “Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy,” Journal of Hypertension, vol. 24, no. 12, pp. 2393–2397, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. D. Conen, R. J. Glynn, J. E. Buring, P. M. Ridker, and R. Y. L. Zee, “Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study,” Journal of Hypertension, vol. 26, no. 9, pp. 1780–1786, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. X. L. Wang, A. S. Sim, R. F. Badenhop, R. M. Mccredie, and D. E. L. Wilcken, “A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene,” Nature Medicine, vol. 2, no. 1, pp. 41–45, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. D. L. S. Rios, L. O. D'Onofrio, J. K. Souza et al., “Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians,” Atherosclerosis, vol. 193, no. 1, pp. 135–141, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. L. R. Cardon and G. R. Abecasis, “Using haplotype blocks to map human complex trait loci,” Trends in Genetics, vol. 19, no. 3, pp. 135–140, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. A. L. B. Jacob-Ferreira and V. C. Sandrim, “Endothelial nitric oxide synthase polymorphisms and hypertension: improved clinical evidence derived from haplotype analysis,” International Journal of Cardiology, vol. 116, no. 1, p. 116, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. V. C. Sandrim, A. C. T. Palei, R. C. Cavalli et al., “eNOS haplotypes associated with gestational hypertension or preeclampsia,” Pharmacogenomics, vol. 9, no. 10, pp. 1467–1473, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. X. Zhu, L. Fejerman, A. Luke, A. Adeyemo, and R. S. Cooper, “Haplotypes produced from rare variants in the promoter and coding regions of angiotensinogen contribute to variation in angiotensinogen levels,” Human Molecular Genetics, vol. 14, no. 5, pp. 639–643, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. P.-Y. Liu, Y.-Y. Zhang, Y. Lu et al., “A survey of haplotype variants at several disease candidate genes: the importance of rare variants for complex diseases,” Journal of Medical Genetics, vol. 42, no. 3, pp. 221–227, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. D. B. Goldstein, “Common genetic variation and human traits,” The New England Journal of Medicine, vol. 360, no. 17, pp. 1696–1698, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. G. D. Kitsios and E. Zintzaras, “Genome-wide association studies: hypothesis-“free” or “engaged”?” Translational Research, vol. 154, no. 4, pp. 161–164, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. “1000 Genomes Project,” 2009, http://www.1000genomes.org/.
  36. G. D. Kitsios and E. Zintzaras, “Genomic convergence of genome-wide investigations for complex traits,” Annals of Human Genetics, vol. 73, no. 5, pp. 514–519, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. E. Zintzaras, G. Kitsios, D. Kent et al., “Genome-wide scans meta-analysis for pulse pressure,” Hypertension, vol. 50, no. 3, pp. 557–564, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. G. Kitsios and E. Zintzaras, “Genetic variation associated with ischemic heart failure: a HuGE review and meta-analysis,” American Journal of Epidemiology, vol. 166, no. 6, pp. 619–633, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. M. Misono, S. Maeda, M. Iemitsu et al., “Combination of polymorphisms in the β2-adrenergic receptor and nitric oxide synthase 3 genes increases the risk for hypertension,” Journal of Hypertension, vol. 27, no. 7, pp. 1377–1383, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus